NHP

National Healthcare Properties, Inc. Real Estate Real Estate Investment Trusts Russell 3000
$15.08Close $428.7MMarket cap $11.94 – $17.0052-week range Nov 4, 2026Next report · after the close

Highlights

Cautions

  • Distribution down-day volume 1.6× up-day volume over 50 sessions
  • Results soon Nov 4, 2026, in 3 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 11%
1wk down 2.8% price change
1mo down 5.5% price change
12-month return up 26% total, dividends included
F-score — — Not assessed
Altman Z — Unknown
P/E — price / earnings
PEG — P/E / EPS growth
P/B 0.7× price / book
Earnings yield up 0.2% EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth down 3% year on year
EPS growth — latest quarter
Sales growth up 3% latest quarter · +3 pts
ROE down 9% return on equity
Free cash margin up 2% $7.0M FCF
D/E 1.74 long-term debt / equity
Net debt / EBITDA 12.1×
Interest cover —EBIT / interest
Piotroski tests

Repair signals

  • FCF turned positive ($-80M → $7M)
  • Long-term debt down 9% ($1.2B → $1.0B)

Trade setup

ATR% 4.6% $0.69 a day · 2×ATR $13.70
RS — vs the universe
Trend — trend template
Relative volume 1.3× vs 50-day average
Up/down volume 0.63 50 sessions
Implied move — no option chain · report Nov 4, 2026

Screen verdict

Did not qualify for any screen.

Warning signs

3 flagged
  • Heavily indebted Net debt is 12.1 times EBITDA — roughly 12 years of earnings before interest, tax and depreciation to repay borrowings in full.
  • Gross margin narrowing Gross margin fell from 37.4% to 36.0%. The company is keeping less of each dollar of sales than it did a year ago.
  • Revenue shrinking Revenue fell 3.3% over the year, from $353.8M to $342.3M.
Last reported Aug 5, 2026
Results reaction Aug 5, 2026+8% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $342.3M -3% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $381.6M FY2021 · $329.4M FY2022 · $335.8M FY2023 · $345.9M FY2024 · $353.8M FY2025 · $342.3M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$57.7M
-$200M $0 FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$75.5M FY2021 · -$85.4M FY2022 · -$79.6M FY2023 · -$72.4M FY2024 · -$190.3M FY2025 · -$57.7M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $7.0M back to a profit
-$100M $0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $41.8M FY2021 · $38.9M FY2022 · $28.3M FY2023 · $21.6M FY2024 · -$79.8M FY2025 · $7.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 36%
  • Net -17%
  • Free cash 2%
-100% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 36% · Net -20% · Free cash 11% FY2021 · Gross 38% · Net -26% · Free cash 12% FY2022 · Gross 36% · Net -24% · Free cash 8% FY2023 · Gross 37% · Net -21% · Free cash 6% FY2024 · Gross 37% · Net -54% · Free cash -23% FY2025 · Gross 36% · Net -17% · Free cash 2%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $988.6M net debt
  • Cash
  • Long-term debt
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $72.4M · Long-term debt $1.2B FY2021 · Cash $59.7M · Long-term debt $1.1B FY2022 · Cash $53.7M · Long-term debt $1.1B FY2023 · Cash $46.4M · Long-term debt $1.2B FY2024 · Cash $21.7M · Long-term debt $1.2B FY2025 · Cash $57.6M · Long-term debt $1.0B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 28.43m +21.3% since FY2020
28.43m 23.44m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 23.44m FY2021 · 24.82m FY2022 · 26.27m FY2023 · 27.89m FY2024 · 28.30m FY2025 · 28.43m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $381.6M $329.4M $335.8M $345.9M $353.8M $342.3M
Gross margin 36% 38% 36% 37% 37% 36%
Operating income -$19.9M -$37.4M -$31.5M -$4.7M -$123.5M $3.3M
Net income -$75.5M -$85.4M -$79.6M -$72.4M -$190.3M -$57.7M
Net margin -20% -26% -24% -21% -54% -17%
Earnings per share -$2.85 -$3.03 -$2.82 -$2.56 -$6.73 -$2.04
Free cash flow $41.8M $38.9M $28.3M $21.6M -$79.8M $7.0M
Free cash margin 11% 12% 8% 6% -23% 2%
Cash $72.4M $59.7M $53.7M $46.4M $21.7M $57.6M
Long-term debt $1.2B $1.1B $1.1B $1.2B $1.2B $1.0B
Shareholders' equity $957.0M $1.0B $992.6M $894.2M $684.6M $600.1M
Shares outstanding 23.44m 24.82m 26.27m 27.89m 28.30m 28.43m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 14, 2026 Quarterly ↗ Mar 31, 2026 44d
Feb 20, 2026 Annual ↗ Dec 31, 2025 51d
Nov 5, 2025 Quarterly ↗ Sep 30, 2025 36d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 8, 2025 Quarterly ↗ Mar 31, 2025 38d
Feb 27, 2025 Annual ↗ Dec 31, 2024 58d
Nov 12, 2024 Quarterly ↗ Sep 30, 2024 43d
Aug 9, 2024 Quarterly ↗ Jun 30, 2024 40d
May 10, 2024 Quarterly ↗ Mar 31, 2024 40d
Mar 15, 2024 Annual ↗ Dec 31, 2023 75d
Nov 13, 2023 Quarterly ↗ Sep 30, 2023 44d

Current reports